4.6 Article

The Small Molecule PPARγ Agonist GL516 Induces Feeding-Stimulatory Effects in Hypothalamus Cells Hypo-E22 and Isolated Hypothalami

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders

Anshul Sanjay et al.

Summary: PPARs are critical nuclear receptors that regulate the expression of numerous genes and play a key role in treating neurodegenerative diseases. Natural phytoconstituents have been identified as PPAR agonists with potential neuroprotective effects. Studies have highlighted the mechanisms of action of these compounds and the potential of using the fruit fly as a model for studying neurodegenerative diseases.

BIOMEDICINES (2021)

Review Chemistry, Medicinal

Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis

Juhee Lim et al.

Summary: This article discusses the role of PPAR gamma in adult neurogenesis. By activating PPAR gamma, it can increase the proliferation and differentiation of neural stem cells, prevent neurodegeneration, and improve cognition, anxiety, and depression-like behaviors.

ARCHIVES OF PHARMACAL RESEARCH (2021)

Review Cell Biology

Astrocyte-neuron metabolic cooperation shapes brain activity

Gilles Bonvento et al.

Summary: The brain has minimal energy reserves and relies on precise coordination between neurotransmission and energy metabolism. Different types of neural cells display unique metabolic signatures, necessitating intercellular exchange of metabolites to sustain brain function. Disruption of this metabolic cooperation may lead to neurological diseases, highlighting the importance of innovative therapies to preserve brain energetics.

CELL METABOLISM (2021)

Review Biochemistry & Molecular Biology

Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target

Tapan Behl et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopamine-generating nerve cells in the substantia nigra pars compacta. The etiology and pathogenesis of PD remain unclear, but genetic and environmental factors are believed to play a role. PPAR agonists have shown neuroprotective effects by modulating the expression of genes involved in cellular survival pathways, suggesting a potential therapeutic target for PD and other neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-γ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury

Ashi Mannan et al.

Summary: PPAR-gamma plays a neuroprotective role in cerebral ischemic injury by negatively controlling the expression of genes modulated by cerebral ischemic injury to prevent post-ischemic inflammation and neuronal damage. It also regulates lipid metabolism, improves insulin sensitivity, reduces oxidative stress, and inhibits inflammation in the brain. This review provides insights into the cellular and molecular mechanisms through which PPAR-gamma exerts its neuroprotective effects in cerebral ischemic injury.

NEUROCHEMICAL RESEARCH (2021)

Review Neurosciences

Reassessment of Pioglitazone for Alzheimer's Disease

Ann M. Saunders et al.

Summary: Alzheimer's disease is a significant unmet medical need in the elderly population, with no treatments available to reduce the risk of developing AD or to offer prolonged mitigation of its devastating symptoms. Despite promising results in pre-clinical experiments and observational studies, placebo-controlled clinical trials have not shown the same efficacy for pioglitazone in delaying the onset of dementia in individuals with pre-existing type 2 diabetes mellitus.

FRONTIERS IN NEUROSCIENCE (2021)

Article Chemistry, Medicinal

Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome

Letizia Giampietro et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Review Chemistry, Medicinal

Development of Fibrates as Important Scaffolds in Medicinal Chemistry

Letizia Giampietro et al.

CHEMMEDCHEM (2019)

Article Clinical Neurology

Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis

Shyuan T. Ngo et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2019)

Article Biochemistry & Molecular Biology

PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line

Letizia Giampietro et al.

NEUROCHEMISTRY INTERNATIONAL (2019)

Article Chemistry, Medicinal

Synthesis, Characterization and Evaluation of Gemfibrozil-stilbene Hybrid as Antioxidant

Rosa Amoroso et al.

LETTERS IN DRUG DESIGN & DISCOVERY (2018)

Article Biochemistry & Molecular Biology

Effects of Kisspeptin-10 on Hypothalamic Neuropeptides and Neurotransmitters Involved in Appetite Control

Giustino Orlando et al.

MOLECULES (2018)

Review Cell Biology

Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation

Sonia Villapol

CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)

Article Endocrinology & Metabolism

Effects of intracerebroventricular injection of rosiglitazone on appetite-associated parameters in chicks

Justin A. Matias et al.

GENERAL AND COMPARATIVE ENDOCRINOLOGY (2017)

Article Cell Biology

Effects of growth hormone-releasing hormone gene targeted ablation on ghrelin-induced feeding

Lucia Recinella et al.

GROWTH HORMONE & IGF RESEARCH (2017)

Article Clinical Neurology

Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis

Martin Gorges et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Review Clinical Neurology

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions

Shyuan T. Ngo et al.

DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE (2017)

Article Chemistry, Medicinal

Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents

Koneni V. Sashidhara et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs

Letizia Giampietro et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Review Endocrinology & Metabolism

PPARs at the crossroads of lipid signaling and inflammation

Walter Wahli et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)

Article Biochemistry & Molecular Biology

A role for central nervous system PPAR-γ in the regulation of energy balance

Karen K. Ryan et al.

NATURE MEDICINE (2011)

Review Cardiac & Cardiovascular Systems

Neuroendocrine control of food intake

Elena Valassi et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)

Review Medicine, Research & Experimental

Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists

Antonietta Bernardo et al.

PPAR RESEARCH (2008)

Article Chemistry, Medicinal

Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid

A Ammazzalorso et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)

Review Immunology

The regulation of feeding: A cross talk between peripheral and central signalling

L Brunetti et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)

Review Pharmacology & Pharmacy

An overview on biological mechanisms of PPARs

BP Kota et al.

PHARMACOLOGICAL RESEARCH (2005)